104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain

Juan Pereyra-Rodriguez, JoseDominguez-Cruz, JavierCarlos Armario-Hita, JoseRuiz-Villaverde, Ricardo2023-02-122023-02-122021-11-090365-0596http://hdl.handle.net/10668/18667enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spainletteropen access10.1016/j.abd.2020.08.0301806-4841https://doi.org/10.1016/j.abd.2020.08.030716855900024